Health claims surrounding cannabis products frequently hit the news. But is there any evidence that they could reduce the risk of breast cancer coming back? Medical cannabis and cannabis oils have been in the news a lot recently. Cannabis contains ingredients called cannabinoids. THC is the chemical responsible for most of the effects that cannabis has on the mind or behaviour.
October is breast cancer awareness month. This tidbit of information may have already been readily apparent by the droves of people dressed in bright pink and neon green shirts racing for the cure down your streets a couple of weekends ago. The Susan G Komen foundation has organized this legion of charitable runners now for the past twenty years, raising hundreds of millions of dollars for cancer research. But this life-saving solution, plant or magic ball —whatever the holy grail of grandma killer cures is supposed to be — was ultimately shut down by the U. S government and is now being kept in a super, secret vault in the basement of the Pentagon. There has been a lot of discussion about marijuana and cancer over the years, so much that it has inspired scientific minds to dig deeper into the subject. But the results have been a mixed bag of noise.
It has been posted here with permission. You can read the original article here and donate to Cancer Research UK here. Humans have been using cannabis plants for medicinal and recreational purposes for thousands of years, but cannabinoids themselves were first purified from cannabis plants in the s. The CB1 and CB2 receptors.
In spite of new drugs, lung cancer is associated with a very poor prognosis. While targeted therapies are improving outcomes, it is not uncommon for many patients to have only a partial response, and relapse during follow-up. Thus, new drugs or re-evaluation of existing therapies used to treat other non-malignant diseases drug repurposing are still needed. While this research both in vitro and in vivo is being carried out, it is important to be attentive to patients where the disease responds to treatments not considered standard in clinical practice. We report here a patient with adenocarcinoma of the lung who, after declining chemotherapy and radiotherapy, presented with tumour response following self-administration of cannabidiol, a non-psychoactive compound present in Cannabis sativa.